Exploring 3-Fluoroamphetamine. To explore a different substance…

IUPAC name:
2130 · C9H12FN · 153.197
PIOCLGPCMNPZFT-UHFFFAOYSA-N This stereoisomer Any stereoisomer

Rõsner, P; Quednow, B; Girreser, U; Junge, T. Isomeric fluoro-methoxy-phenylalkylamines: A new series of controlled-substance analogues (designer drugs). Forensic Sci. Int., 1 Jan 2004, 148 (2–3), 143–156. 282 kB. https://doi.org/10.1016/j.forsciint.2004.05.003

Rothman, RB; Blough, BE; Baumann, MH. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction. Trends Pharmacol. Sci., 1 Dec 2006, 27 (12), 612–618. 519 kB. https://doi.org/10.1016/j.tips.2006.10.006

Rothman, RB; Blough, BE; Baumann, MH. Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J., 2007, 9 (1), E1–E10. 999 kB. https://doi.org/10.1208/aapsj0901001

Westphal, F; Rõsner, P; Junge, T. Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry. Forensic Sci. Int., 30 Jan 2010, 194 (1–3), 53–59. 521 kB. https://doi.org/10.1016/j.forsciint.2009.10.007

Nakanishi, K; Miki, A; Zaitsu, K; Kamata, H; Shima, N; Kamata, T; Katagi, M; Tatsuno, M; Tsuchihashi, H; Suzuki, K. Cross-reactivities of various phenethylamine-type designer drugs to immunoassays for amphetamines, with special attention to the evaluation of the one-step urine drug test Instant-View™, and the Emit® assays for use in drug enforcement. Forensic Sci. Int., 10 Apr 2012, 217 (1–3), 174–181. 397 kB. https://doi.org/10.1016/j.forsciint.2011.11.003

Baumann, MH; Clark, RD; Woolverton, WL; Wee, S; Blough, BE; Rothman, RB. In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J. Pharmacol. Exp. Ther., 1 Apr 2011, 337 (1), 218–225. 380 kB. https://doi.org/10.1124/jpet.110.176271

Segawa, H; Iwata, YT; Yamamuro, T; Kuwayama, K; Tsujikawa, K; Kanamori, T; Inoue, H. Differentiation of ring-substituted regioisomers of amphetamine and methamphetamine by supercritical fluid chromatography: Differentiation of ring-substituted regioisomers by supercritical fluid chromatography. Drug Test. Analysis, 1 Jan 2016, 9 (3), 389-398. 1.3 MB. https://doi.org/10.1002/dta.2040

King, LA. New phenethylamines in Europe. Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570

Vidal Giné, C; Espinosa, IF; Vilamala, MV. New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Test. Analysis, 1 Jul 2014, 6 (7-8), 819-824. 113 kB. https://doi.org/10.1002/dta.1610

Biel, JH; Bopp, BA. Amphetamines: Structure-activity relationships. In Handbook of Psychopharmacology: Stimulants; Iversen, LL; Iversen, SD; Snyder, SH, Eds., Plenum Press, New York, 1978; Vol. 11, pp 1–39. 1.0 MB. https://doi.org/10.1007/978-1-4757-0510-2_1

Grumann, C; Auwärter, V. Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry. Drug Test. Analysis, 1 Jul 2018, 10 (7), 1184–1191. 861 kB. https://doi.org/10.1002/dta.2371 #3-FA LC,MS

Takahashi, M; Nagashima, M; Suzuki, J; Seto, T; Yasuda, I; Yoshida, T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry. Talanta, 15 Feb 2009, 77 (4), 1245–1272. 1.2 MB. https://doi.org/10.1016/j.talanta.2008.07.062 #3FMP

Wee, S; Anderson, KG; Rothman, RB; Bough, BE; Woolverton, WL. Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J. Pharmacol. Exp. Ther., 1 May 2005, 313 (2), 848–254. 171 kB. https://doi.org/10.1124/jpet.104.080101 #m-fluoroamphetamine (PAL 353)

EMCDDA. New drugs in Europe, 2009, European Monitoring Centre for Drugs and Drug Addiction, 1 May 2010. 321 kB. #1

4-FA · 4-Fluoroamphetamine
2F-AMP · 2-Fluoroamphetamine
24 September 2018 · Creative Commons BY-NC-SA ·